Arrowhead Pharmaceuticals
ARWR
#1951
Rank
NZ$17.95 B
Marketcap
NZ$128.20
Share price
0.96%
Change (1 day)
445.81%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): NZ$0.62 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are NZ$1.09 Billion. , an increase over its 2024 earnings that were of -NZ$1.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.58 B-157.5%
2024 -NZ$1.02 Billion112.45%
2023 -NZ$0.48 Billion87.79%
2022 -NZ$0.26 Billion-20.1%
2021 -NZ$0.32 Billion67.59%
2020 -NZ$0.2 Billion-347.53%
2019 NZ$77.04 M-245.59%
2018 -NZ$52.92 Million-13.17%
2017 -NZ$60.95 Million-52.28%
2016 -NZ$0.13 Billion-16.57%
2015 -NZ$0.16 Billion30.32%
2014 -NZ$0.12 Billion171.62%
2013 -NZ$43.25 Million16.56%
2012 -NZ$37.11 Million107.53%
2011 -NZ$17.88 Million
2008 -NZ$62.98 Million-8.07%
2007 -NZ$68.51 Million70.37%
2006 -NZ$40.21 Million122.51%
2005 -NZ$18.08 Million147.41%
2004 -NZ$7.31 Million2002.28%
2003 -NZ$0.35 Million-85.61%
2002 -NZ$2.42 Million1371.97%
2001 -NZ$0.17 Million-13.45%
2000 -NZ$0.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$56.94 B 9,621.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$4.69 Billion-899.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.27 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.2 Billion-134.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.97 B 66.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-NZ$0.19 Billion-131.32%๐Ÿ‡บ๐Ÿ‡ธ USA